Advertisement
Research Article Free access | 10. 1172/JCI114630 VSports.
Oncology Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231.
Find articles by Falco, J V体育官网. in: PubMed | Google Scholar .
Oncology Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231.
Find articles by Baylin, S V体育安卓版. in: PubMed | Google Scholar .
Oncology Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231.
Find articles by Lupu, R. in: PubMed | Google Scholar VSports最新版本.
Oncology Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231.
Find articles by Borges, M. in: PubMed | Google Scholar VSports注册入口.
Oncology Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231.
Find articles by Nelkin, B. in: PubMed | Google Scholar VSports在线直播.
Oncology Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231.
Find articles by Jasti, R. in: PubMed | Google Scholar VSports.
Oncology Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231.
Find articles by Davidson, N. in: PubMed | Google Scholar V体育官网.
Oncology Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231.
Find articles by Mabry, M. in: PubMed | Google Scholar V体育安卓版.
Published June 1, 1990 - More info
Small cell lung cancer (SCLC) tumor progression can involve partial or complete conversion to a more treatment-resistant non-small cell (NSCLC) phenotype. In a cell culture model of this phenomenon, we have previously demonstrated that insertion of the viral Harvey ras gene (v-Ha-ras) into SCLC cell lines with amplification and overexpression of the c-myc gene induced many NSCLC phenotypic features V体育ios版. We now report that the v-Ha-ras gene can also induce morphologic, biochemical, and growth characteristics consistent with the NSCLC phenotype in an N-myc amplified SCLC cell line, NCI-H249. We show that v-Ha-ras has novel effects on these cells, abrogating an SCLC-specific growth requirement for gastrin-releasing peptide, and inducing mRNA expression of three NSCLC-associated growth factors and receptors, platelet-derived growth factor B chain, transforming growth factor-alpha (TGF-alpha), and epidermal growth factor receptor (EGF-R). TGF-alpha secretion and EGF-R also appear, consistent with the induction of an autocrine loop previously shown to be growth stimulatory for NSCLC in culture. These data suggest that N-myc and v-Ha-ras represent functional classes of genes that may complement each other in bringing about the phenotypic alterations seen during SCLC tumor progression, and suggest that such alterations might include the appearance of growth factors and receptors of potential importance for the growth of the tumor and its surrounding stroma.
Images.